| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
273,070,000 |
| Market
Cap: |
1.87(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.09 - $15.52 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
| Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
27 |
| Total Shares Sold |
366,682 |
934,542 |
1,871,955 |
3,338,528 |
| Total Sell Value |
$2,558,035 |
$7,544,746 |
$16,254,185 |
$30,762,522 |
| Total People Sold |
4 |
4 |
7 |
8 |
| Total Sell Transactions |
21 |
44 |
89 |
167 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-07 |
4 |
AS |
$6.53 |
$240,238 |
D/D |
(36,718) |
314,534 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
333,034 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-07 |
4 |
OE |
$2.48 |
$109,145 |
D/D |
44,010 |
332,752 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
AS |
$6.55 |
$16,406 |
I/I |
(2,500) |
0 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
AS |
$6.56 |
$242,713 |
D/D |
(35,826) |
288,742 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
307,242 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
OE |
$2.48 |
$109,145 |
D/D |
44,010 |
306,068 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
AS |
$7.31 |
$18,284 |
I/I |
(2,500) |
0 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
AS |
$7.31 |
$256,234 |
D/D |
(34,472) |
262,058 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
280,558 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
OE |
$2.48 |
$109,145 |
D/D |
44,010 |
278,030 |
|
- |
|
| Burrell Terry-Ann |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,788 |
136,373 |
|
- |
|
| Borgeson Blake |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,300 |
7,652,446 |
|
- |
|
| Bogue Zachary |
Director |
– • • |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,382 |
2,752 |
|
- |
|
| Chavez R Martin Phd |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,438 |
11,107 |
|
- |
|
| Li Dean Y |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,544 |
599,466 |
|
- |
|
| Doyle Ramona |
Chief Medical Officer |
• – – |
2022-03-31 |
4 |
OE |
$2.48 |
$22,499 |
D/D |
9,072 |
121,942 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
S |
$6.08 |
$37,407 |
D/D |
(6,150) |
234,020 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,150 |
240,170 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-14 |
4 |
S |
$6.28 |
$1,444,814 |
D/D |
(230,000) |
234,020 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
230,000 |
464,020 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
S |
$6.95 |
$694,580 |
D/D |
(100,000) |
234,020 |
|
- |
|
| Gibson Christopher |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
334,020 |
|
- |
|
628 Records found
|
|
Page 20 of 26 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.17 (2.55%) 
